4D Molecular Therapeutics (FDMT)
NASDAQ:FDMT
US Market
Holding FDMT?
Track your performance easily

4D Molecular Therapeutics (FDMT) Balance Sheet

280 Followers

4D Molecular Therapeutics Balance Sheet

4D Molecular Therapeutics's total assets for Q2 2024 were $620.12M, a decrease of -1.55% from the previous quarter. FDMT total liabilities were $31.78M for the fiscal quarter, a 8.37% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 339.89M$ 261.85M$ 353.49M$ 288.33M$ 58.23M
Total Liabilities
$ 32.06M$ 30.51M$ 34.38M$ 31.94M$ 131.20M
Total Equity Gross Minority
$ 307.86M$ 231.33M$ 319.11M$ 256.39M$ -72.97M
Total Capitalization
$ 319.35M$ 244.81M$ 319.11M$ 256.39M$ -72.97M
Preferred Stock Equity
-----
Capital Lease Obligations
---$ 0.00-
Currency in USD

4D Molecular Therapeutics Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis